Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 6 of 6 clinical reviews.
No direct drug interaction exists between 5-HTP and denosumab (Prolia), but 5-HTP raises peripheral serotonin, which may blunt bone formation. Here is what the evidence says about safety, monitoring, and dose-separation.
Read clinical reviewEvidence-based guide on combining alpha-lipoic acid supplements with Prolia (denosumab) for osteoporosis, covering interaction mechanisms, safety data, monitoring, and dose-separation recommendations.
Read clinical reviewEvidence-based guide on the safety of combining NAC supplements with Prolia (denosumab) for osteoporosis, including pharmacokinetic considerations, monitoring, and clinical recommendations.
Read clinical reviewReishi mushroom may interact with Prolia (denosumab) through immune modulation and anticoagulant effects. Learn the risks, monitoring needs, and dose-separation strategies.
Read clinical reviewVitamin B12 and Prolia (denosumab) have no direct drug-supplement interaction. Learn why B12 monitoring still matters during osteoporosis treatment, especially if you also take metformin.
Read clinical reviewVitamin D supplementation is recommended, not just safe, during Prolia (denosumab) therapy. Learn about dosing, monitoring, and why correcting vitamin D deficiency before starting denosumab matters.
Read clinical review